Standout Papers

Role of <i>KRAS</i> and <i>EGFR</i> As Biomarkers of Response to Erlotinib in Nat... 2005 2026 2012 2019 1.5k
  1. Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 (2008)
    Chang‐Qi Zhu, Gilda da Cunha Santos et al. Journal of Clinical Oncology
  2. Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome (2005)
    Ming‐Sound Tsao, Akira Sakurada et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 16 from Science/Nature 83 standout
Sub-graph 1 of 16

Citing Papers

Comprehensive Integration of Single-Cell Data
2019 Standout
The emerging role of cell-free DNA as a molecular marker for cancer management
2019 Standout
1 intermediate paper

Works of Paula Marrano being referenced

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue
2004

Author Peers

Author Last Decade Papers Cites
Paula Marrano 1625 2208 358 1922 60 3.9k
Nicolò Riggi 3131 1353 217 1167 49 4.6k
Leah Haworth 1941 1183 440 3184 21 6.0k
Franck Tirode 2455 2043 282 1238 109 4.4k
Irina A. Lubensky 1571 1099 364 1265 65 3.7k
David Hogg 3206 1060 414 3865 121 6.2k
James R. Gnarra 3822 1375 606 1150 66 5.8k
Jim Heighway 2317 649 296 1580 72 3.4k
Martina Mirlacher 2164 1539 376 2487 62 5.2k
Ryma Benayed 1015 2088 167 1476 84 3.9k
M. OʼReilly 3685 736 444 1843 30 6.0k

All Works

Loading papers...

Rankless by CCL
2026